Medicxi Ventures Management (Jersey) Ltd
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1715579
ST. HELIER, Y9
Position in NAMS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$74,850,775
-$10,749,790 QoQ
Shares Held
2,208,639
-17.4% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
42.19%
of 13F equity value
Holder Rank
#12
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Medicxi Ventures Management (Jersey) Ltd holds $177,424,614 across 3 Biotechnology names. NAMS ranks #2 (42.2% of the industry book) .
All Filings in NAMS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,850,775 | 2,208,639 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $85,600,565 | 2,674,182 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $100,664,340 | 2,869,565 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $81,610,428 | 2,869,565 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $51,967,822 | 2,869,565 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $58,739,995 | 2,869,565 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $73,747,820 | 2,869,565 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $47,634,779 | 2,869,565 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $55,124,343 | 2,869,565 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $67,865,212 | 2,869,565 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $32,053,041 | 2,869,565 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $26,543,476 | 2,869,565 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $34,119,127 | 2,869,565 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $26,520,000 | 2,000,000 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $21,800,000 | 2,000,000 | Shares | Sole | 2023-01-31 | |
| No filing history on record for this holder in this stock. | ||||||